Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.45 EUR | +0.78% | -16.77% | -27.69% |
Apr. 23 | EMEA Morning Briefing : Shares Set to Rise as Geopolitical Concerns Ease | DJ |
Apr. 17 | South Africa's PetroSA targets Mozambique gas in new sales deal | RE |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Its low valuation, with P/E ratio at 3.25 and 2.54 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The stock, which is currently worth 2024 to 0.62 times its sales, is clearly overvalued in comparison with peers.
- The company appears to be poorly valued given its net asset value.
- The company is one of the best yield companies with high dividend expectations.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-27.69% | 4.28B | - | ||
-0.19% | 80.96B | B | ||
+0.09% | 48.75B | A- | ||
-4.19% | 30.73B | C | ||
+9.85% | 17.82B | B | ||
-10.05% | 11.7B | B | ||
-8.09% | 9.65B | - | ||
+2.79% | 9.52B | A- | ||
+6.35% | 9.39B | C- | ||
+3.85% | 8.2B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SOL Stock
- SAOA Stock
- Ratings Sasol Limited